In addition, the combination of PI4KB-Peptide-1 and trametinib exhibited superior efficacy than chloroquine plus trametinib in inhibiting tumor growth, preserving normal pancreatic tissue, and extending survival periods (Fig. 10d–f). This evidence concerns the gene PI4KB and neoplasm.